MapLight Therapeutics (MPLT) Change in Cash (2024 - 2025)

MapLight Therapeutics (MPLT) reported Change in Cash of -$17.4 million for Q4 2025, down 259.63% on a YoY basis from $10.9 million in Q4 2024, and down 259.63% sequentially from $10.9 million in Q4 2024.

MapLight Therapeutics (MPLT) Change in Cash (2024 - 2025) Analysis & Trends

MapLight Therapeutics (MPLT) has 2 years of Change in Cash data on file, last reported at -$17.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -22.03 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 243.78 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 417.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -153.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 MapLight Therapeutics 305.82 Mn 305.82 Mn - -17.42 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.42 Mn
Dec 31, 2024 10.91 Mn